These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18318249)

  • 41. Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
    Mandell LA; Jones RN
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):127-8. PubMed ID: 12376042
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience.
    Milkovich G
    Pharmacotherapy; 2001 Jul; 21(7 Pt 2):83S-88S. PubMed ID: 11446523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocarditis diagnosed as multilobar, community acquired pneumonia.
    Muntan CD; Haydel M
    Emerg Med J; 2004 Mar; 21(2):244-5. PubMed ID: 14988364
    [No Abstract]   [Full Text] [Related]  

  • 44. 52-year-old man with shortness of breath.
    Aviles RJ; Dockrell DH; Thompson RL
    Mayo Clin Proc; 2000 Apr; 75(4):417-20. PubMed ID: 10761500
    [No Abstract]   [Full Text] [Related]  

  • 45. Investigation of the clinical efficacy and dosage of intravenous ciprofloxacin in patients with respiratory infection.
    Matsuo K; Azuma M; Kasai M; Hanji I; Kimura I; Kosugi T; Suga N; Satoh M
    J Pharm Pharm Sci; 2009 Jan; 11(2):111s-117s. PubMed ID: 19203473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Community-acquired pneumonia in the fragile elderly].
    Marti J; Novo I
    Rev Esp Geriatr Gerontol; 2008; 43(6):388-9. PubMed ID: 19080957
    [No Abstract]   [Full Text] [Related]  

  • 47. [Community acquired pneumonia by Corynebacterium spp. in a immunocompetent patient].
    Chico C; Batalla B; Javaloyas M; Rodríguez E
    An Med Interna; 2007 Feb; 24(2):100-1. PubMed ID: 17595737
    [No Abstract]   [Full Text] [Related]  

  • 48. Community acquired pneumonia. CME Infectious diseases--II.
    Jolobe OM
    J R Coll Physicians Lond; 1998; 32(5):491-2. PubMed ID: 9819750
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis and treatment of mycoplasma-contaminated cell cultures.
    Harlin H; Gajewski TF
    Curr Protoc Cytom; 2008 Jan; Appendix 3():Appendix 3C. PubMed ID: 18770641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Myeloradiculoneuritis of Mycoplasma pneumoniae: a case report].
    Loussaief C; Battikh R; Louzir B; M'saddek F; Abdelhafidh NB; Bahri M; Mâalaoui H; Ajmi F; Othmani S
    Rev Med Interne; 2003 Apr; 24(4):273-5. PubMed ID: 12706790
    [No Abstract]   [Full Text] [Related]  

  • 51. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization.
    Erdem G; Staat MA; Connelly BL; Assa'ad A
    Pediatr Infect Dis J; 1999 Jun; 18(6):563-4. PubMed ID: 10391195
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of oral ciprofloxacin in community-acquired pneumonia.
    Chrysanthopoulos CJ; Bassaris HP
    J Chemother; 1989 Apr; 1(2):103-6. PubMed ID: 2732778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidisciplinary approach to improving treatment of community-acquired pneumonia.
    Cregin R; Segal-Maurer S; Weinbaum F; Rahal J; Kabrowitz S; Sixsmith D; Cassata V; Danek M; Battleman D; Callahan M
    Am J Health Syst Pharm; 2002 Feb; 59(4):364-8. PubMed ID: 11885401
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of primary atypical pneumonia with intravenous doxycycline: a report of clinical observations.
    Coll J; Cabrer B; Cano JF; Vivancos J; Balcells A
    Infection; 1976; 4(1 Suppl):53-4. PubMed ID: 955702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.
    Somasundaram C; Nicklas W; Matzku S
    In Vitro Cell Dev Biol; 1992; 28A(11-12):708-10. PubMed ID: 1483961
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mycoplasma infection].
    Kitamoto O
    Kansenshogaku Zasshi; 1970 Jan; 43(10):251-5. PubMed ID: 4985499
    [No Abstract]   [Full Text] [Related]  

  • 57. Reversible encephalopathy after intravenous ciprofloxacin therapy.
    Rfidah EI; Findlay CA; Beattie TJ
    Pediatr Nephrol; 1995 Apr; 9(2):250-1. PubMed ID: 7794728
    [No Abstract]   [Full Text] [Related]  

  • 58. Mycoplasma pneumonia.
    Forsyth BR; Chanock RM
    Annu Rev Med; 1966; 17():371-82. PubMed ID: 5327164
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of ciprofloxacin for the elimination of mycoplasma from naturally infected cell lines.
    Mowles JM
    Cytotechnology; 1988 Nov; 1(4):355-8. PubMed ID: 22359171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical effects of intravenous ciprofloxacin on community-acquired pneumonia with positive Immunocard Mycoplasma test results].
    Okimoto N; Nanba F; Kibayashi T; Kishimoto M; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N
    Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):92-5. PubMed ID: 18318249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.